ARTICLE | Clinical News
BIO-11006 Inhalation Solution: Phase II ongoing
April 27, 2009 7:00 AM UTC
BioMarck said an independent safety monitoring committee recommended continuation of the double-blind, placebo-controlled, U.S. Phase II BREATH-1 trial based on a review of safety data from the first ...